Immunologic correlates of protection induced by vaccination
- 1 January 2001
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 20 (1) , 63-75
- https://doi.org/10.1097/00006454-200101000-00013
Abstract
Vaccine design and licensing depend on the choice of protective antigens and the demonstration of their efficacy. Ideally efficacy correlates with some measurement of immune response, although occasionally the correlation is weak and in the case of some vaccines uncertain. This paper attempts to review what is known about correlates of vaccine-induced protection. Although mucosal and cellular immune responses are clearly important to protection by some vaccines, most vaccines licensed today depend for their efficacy on serum antibodies. Particular levels of antibodies can be identified that confer protection most of the time. A condition for the efficacy of antibodies is functionality, i.e. their ability to kill or inactivate pathogens. The immune system is redundant, and the different types of responses to vaccines act synergistically.Keywords
This publication has 122 references indexed in Scilit:
- Meningococcal VaccinesDrugs, 1998
- Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigenThe Journal of Pediatrics, 1995
- Difficulties in Establishing a Serological Correlate of Protection After Immunization with Haemophilus Influenzae Conjugate VaccinesBiologicals, 1994
- Responses to measles immunization in children infected with human immunodeficiency virusThe Journal of Pediatrics, 1994
- Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccinesThe Journal of Pediatrics, 1992
- Persistence of Immunity to Varicella in Children with Leukemia Immunized with Live Attenuated Varicella VaccineNew England Journal of Medicine, 1989
- Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide ofSalmonella TyphiNew England Journal of Medicine, 1987
- Prevention ofHaemophilus influenzaeType b Infections in High-Risk Infants Treated with Bacterial Polysaccharide Immune GlobulinNew England Journal of Medicine, 1987
- Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody levelThe Journal of Pediatrics, 1981
- The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B virusesEpidemiology and Infection, 1972